Find the Perfect Plan for Your Investment Journey
i
Latest price
52 Week Range
CA$0.01 - CA$0.04
Next Earnings Date
May 12 2025
Next Earnings Date
May 12 2025
Latest price
Market Cap | CA$67.46M |
EV | CA$343.59M |
Shares Outstanding | 6.75B |
Beta | 0.02 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | -6.20% |
EPS | 86.30% |
Operating Cash Flow | -8.10% |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
i
iAnthus Capital Holdings, Inc.
IAN
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Proud, Richard
Employees
775
Website
www.ianthus.comIPO Date
2016-09-07
Headquarters
214 King Street West, Suite 314, Toronto, Ontario, M5H 3S6, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved